home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Subverting A Metabolic Pathway For Tumour Growth

 
  March, 20 2008 8:29
your information resource in human molecular genetics
 
     

Tumour cells generally use altered metabolic pathways for energy production, in particular they display a switch in the way glucose is metabolized. Although this aberration was first noticed by Otto Warburg some 80 years ago, two papers in Nature shed further light on the mechanisms underlying this switch.

Lewis Cantley and colleagues looked at pyruvate kinase - an enzyme involved in glucose metabolism - which exists in some cancer cells in an embryonic form known as M2. By making the cells produce the adult (M1) form instead, the team were able to set cancer cells back on to their normal metabolic course and curb the cells' tumour-forming capacity. In an accompanying paper, they reveal how M2 pyruvate kinase is subject to internal controls that do not affect M1, which may explain the different modes of glucose metabolism in cancer cells.

The discovery that M2 aids tumour growth demonstrates the importance of the specialized metabolism of cancer cells, say the authors.

CONTACT

Lewis Cantley (Beth Israel Deaconess Medical Center, Boston, MA, USA)
E-mail: lcantley@hms.harvard.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.